Literature DB >> 11516728

Changes of the brain electrical fields during the continuous performance test in attention-deficit hyperactivity disorder-boys depending on methylphenidate medication.

K E Zillessen1, P Scheuerpflug, A J Fallgatter, W K Strik, A Warnke.   

Abstract

OBJECTIVE: The continuous performance test (CPT) is successfully applied to evaluate attentional performance in attention-deficit hyperactivity disorder (ADHD)-children. The aim of the present study was to investigate the changes of the topographic P300-features in relation to methylphenidate-medication and to different attentional processes in primer- and distractor-conditions.
METHODS: Twenty-one-channel-ERPs of 17 ADHD-boys were analyzed with reference-independent methods. Four quasi stable microstates within the time frames of conventional P100, P200, P3a and P3b components were identified by means of a data-driven segmentation procedure.
RESULTS: In segment 3 topographical assessment yielded a significant occipital and right-shift of the positive centroid, longer centroid distance and higher amplitudes in primer- than in distractor conditions. MPH increased the amplitude and distance in primer and distractor-condition, without changing the topography. In segment 4 the electric field strength of distractor-conditions collapsed, whereas the primer condition showed a strong fronto-parietally oriented potential-field. There was a tendency to higher amplitudes due to MPH-medication.
CONCLUSIONS: These results indicate a robust neurophysiologic differentiation of cognitive processes. MPH activates an early (P3a) covert attention process indicated by increased amplitudes and centroid. No effects were seen in later processes. Based on these effects, we propose to use the amplitude- and distance-increase in microstate 3 as an indicator of MPH efficacy in ADHD-boys.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11516728     DOI: 10.1016/s1388-2457(01)00535-1

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  6 in total

1.  ADHD medication reduces cotinine levels and withdrawal in smokers with ADHD.

Authors:  Jean-G Gehricke; Nuong Hong; Timothy L Wigal; Vivien Chan; Ashley Doan
Journal:  Pharmacol Biochem Behav       Date:  2011-02-26       Impact factor: 3.533

2.  Methylphenidate effects in attention deficit/hyperactivity disorder: electrodermal and ERP measures during a continuous performance task.

Authors:  Carlie A Lawrence; Robert J Barry; Adam R Clarke; Stuart J Johnstone; Rory McCarthy; Mark Selikowitz; Samantha J Broyd
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

3.  Influence of stimulant medication and response speed on lateralization of movement-related potentials in attention-deficit/hyperactivity disorder.

Authors:  Stephan Bender; Franz Resch; Christoph Klein; Tobias Renner; Andreas J Fallgatter; Matthias Weisbrod; Marcel Romanos
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

Review 4.  Sensory processing and P300 event-related potential correlates of stimulant response in children with attention-deficit/hyperactivity disorder: A critical review.

Authors:  Virginia Peisch; Tara Rutter; Carol L Wilkinson; Anne B Arnett
Journal:  Clin Neurophysiol       Date:  2021-02-05       Impact factor: 3.708

5.  Sustained attention in intellectually gifted children assessed using a continuous performance test.

Authors:  Jiannong Shi; Ting Tao; Wei Chen; Li Cheng; Long Wang; Xingli Zhang
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

6.  Transcranial Alternating Current Stimulation (tACS) as a Tool to Modulate P300 Amplitude in Attention Deficit Hyperactivity Disorder (ADHD): Preliminary Findings.

Authors:  Isa Dallmer-Zerbe; Fabian Popp; Alexandra Philomena Lam; Alexandra Philipsen; Christoph Siegfried Herrmann
Journal:  Brain Topogr       Date:  2020-01-23       Impact factor: 3.020

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.